COMBINATION THERAPY WITH RADIOLABELED ANTI-CD20 ANTIBODY IN THE TREATMENT OF B-CELL LYMPHOMA

摘要

A method of treating B-cell lymphoma comprises administering to a patient a chemotherapeutic regimen, followed by treatment with a radiolabeled anti-CD20 antibody, wherein at the time of said treatment with said radiolabeled antibody said patient is not refractory to said chemotherapeutic regimen and has not relapsed.